GSK plans to invest more than $800 million to expand its Upper Merion Township site in Montgomery County, Pennsylvania, creating a biopharmaceutical research and manufacturing hub.
The project is expected to add more than 300 jobs over five years and retain about 4,500 existing GSK jobs across Pennsylvania. Construction is planned to start in 2027.
The hub will bring together commercial-scale biologics manufacturing, an R&D pilot plant, a centralized quality-control lab, manufacturing science and technology capabilities, and digital operations.
The expansion follows GSK’s separate, up-to-$800 million project in Marietta, Lancaster County, announced in 2024. Together, the Pennsylvania investments total nearly $1.7 billion.
Pennsylvania says GSK will be eligible for state manufacturing tax incentives. The headline’s reference to bonds is not reflected in the available reports, which describe tax incentives rather than a bond financing package.
Sources:
Gov. Shapiro Secures Investment from GSK Growing Life ...
Pennsylvania says GSK to invest more than $800 million in ...
GSK pledges $800M to add biologics production capabilities in Pennsylvania
GSK investing $800 million to expand in Montgomery County
Pennsylvania Governor announces $800M investment from GSK in biopharma hub
GSK Commits Over $800 Million to Montgomery County Expansion
GSK pledges $800M to upgrade its R&D, manufacturing in ...
GSK to expand its Montco operations, add more than 300 jobs
Pennsylvania Says GSK to Invest More than $800 Million in Biopharma Hub, Create 300 Jobs
GSK Plans More Than $800 Million Expansion in Pennsylvania | TokenPost
GSK to expand Pennsylvania presence with over $800M investment
GSK plc Stock Price: Quote, Forecast, Splits & News (GSK)
GSK invests up to $800 million in Pennsylvania site, largest ...
Pennsylvania says GSK to invest more than $800 million in ...
Drug maker GSK will invest $800 million in its Lancaster County facility [update]